Novartis/Aventis Consumer Products Combo Would Be Divested
This article was originally published in The Tan Sheet
Executive Summary
Novartis would spin-off a combination of its consumer health products and Aventis' older drugs if the two companies were to merge
You may also be interested in...
Sanofi-Aventis Combo Leaves Allegra In Rx Territory For Now
Allegra's status as a prescription-only drug appears to be secure in the near-term now that Aventis has accepted Sanofi-Synthelabo's sweetened hostile bid for the company
Sanofi-Aventis Combo Leaves Allegra In Rx Territory For Now
Allegra's status as a prescription-only drug appears to be secure in the near-term now that Aventis has accepted Sanofi-Synthelabo's sweetened hostile bid for the company
Sanofi-Aventis Combo Leaves Allegra In Rx Territory For Now
Allegra's status as a prescription-only drug appears to be secure in the near-term now that Aventis has accepted Sanofi-Synthelabo's sweetened hostile bid for the company